血葡萄糖样:慢性病中内皮损伤的镜子
Gemma Valera1, Andrea Figuer2,3, Jara Caro4
1Departamento de Genética, Fisiología y Microbiología, Facultad de Ciencias Biológicas, Universidad Complutense de Madrid/Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Clinical kidney journal
|August 2, 2023
概括
慢性病 (CKD) 中升高的甲酸与促炎性单细胞相关. 然而,decorin可能会减少单细胞炎症,这表明这两种药物都是CKD患者内皮损伤的潜在标志物.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管医学 心血管医学
- 免疫学 免疫学 免疫学
背景情况:
- 慢性病 (CKD) 与内皮损伤和心血管疾病风险增加有关.
- 微炎症和内皮损伤有助于在CKD患者中观察到的高血动性.
- 在CKD中注意到内皮葡萄糖分解产物含量升高,包括perlecan和decorin.
研究的目的:
- 调查血perlecan和decorin水平与慢性病中的炎症和原性状态之间的关联.
- 探索这些标记物与单细胞亚群和细胞内粘附分子 (ICAM) - 1表达在CKD患者之间的关系.
主要方法:
- 该研究包括17名健康对照组和109名CKD患者 (晚期CKD,血液透析,腹腔透析,移植).
- 使用酶相关的免疫吸收试验量化了血中的珀莱干和迪科林水平.
- 单细胞表型,包括ICAM-1表达,通过直接免疫光和流细胞计分析.
主要成果:
- 与对照组相比,CKD患者的血perlecan水平显著更高.
- 较高的perlecan水平与ICAM-1阳性单细胞的患病率增加相关.
- 晚期CKD患者表现出较高的德科林水平,与单细胞上ICAM-1表达的减少有关.
结论:
- 慢性瘤中升的珀莱干可能表明与增加的ICAM-1阳性单细胞相关的促炎状态.
- 升高的德科林可能起到单细胞上ICAM-1表达的负调节者的作用.
- 珀莱肯和德科林显示出在CKD中具有潜在的炎症,单细胞激活和内皮损伤的生物标志物.
相关概念视频
01:20Renal Corpuscle
2.7K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
2.7K
01:24Chronic Kidney Disease II: Clinical Manifestations
30
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
30
01:25Chronic Kidney Disease I: Introduction
36
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
36
01:28Chronic Kidney Disease III: Interprofessional Care
42
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42
01:29Acute Kidney Injury II: Pathophysiology
31
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
31
01:29Acute Kidney Injury III: Clinical Manifestations
34
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
34